Growth Metrics

Eli Lilly (LLY) Gross Margin (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -59.00
Dec 31, 2025 -39.00
Sep 30, 2025 -136.00
Jun 30, 2025 175.00
Mar 31, 2025 28.00
Dec 31, 2024 122.00
Sep 30, 2024 22.00
Jun 30, 2024 -11.00
Mar 31, 2024 3.00
Dec 31, 2023 47.00
Sep 30, 2023 216.00
Jun 30, 2023 163.00
Mar 31, 2023 -217.00
Dec 31, 2022 155.00
Sep 30, 2022 -70.00
Jun 30, 2022 448.00
Mar 31, 2022 -90.00
Dec 31, 2021 -450.00
Sep 30, 2021 785.00
Jun 30, 2021 -138.00
Mar 31, 2021 -449.00
Dec 31, 2020 -1.00
Sep 30, 2020 -88.00
Jun 30, 2020 -148.00
Mar 31, 2020 24.00
Dec 31, 2019 48.00
Sep 30, 2019 -150.00
Jun 30, 2019 240.00
Mar 31, 2019 -232.00
Dec 31, 2018 168.00
Sep 30, 2018 38.00
Jun 30, 2018 136.00
Mar 31, 2018 324.00
Dec 31, 2017 134.00
Sep 30, 2017 -105.00
Jun 30, 2017 -120.00
Mar 31, 2017 -33.00
Dec 31, 2016 153.00
Sep 30, 2016 12.00
Jun 30, 2016 9.00
Mar 31, 2016 -135.00
Dec 31, 2015 -90.00
Sep 30, 2015 -47.00
Jun 30, 2015 121.00
Mar 31, 2015 -121.00
Dec 31, 2014 152.00
Sep 30, 2014 -188.00
Jun 30, 2014 200.00
Mar 31, 2014 -224.00
Dec 31, 2013 -311.00
Sep 30, 2013 -110.00
Jun 30, 2013 103.00
Mar 31, 2013 28.00
Dec 31, 2012 116.00
Sep 30, 2012 -164.00
Jun 30, 2012 91.00
Mar 31, 2012 48.00
Dec 31, 2011 -9.00
Sep 30, 2011 -213.00
Jun 30, 2011 57.00
Mar 31, 2011 -29.00
Dec 31, 2010 -192.00
Sep 30, 2010 32.00
Jun 30, 2010 214.00
Mar 31, 2010 366.00
Dec 31, 2009 -459.00
Sep 30, 2009 -163.00
Jun 30, 2009 -172.00